Difference between revisions of "Part:BBa K2804002:Design"

 
 
(5 intermediate revisions by the same user not shown)
Line 7: Line 7:
  
 
===Design Notes===
 
===Design Notes===
−
The mature form of BMP2 was considered to fuse it to CBD cipA.
+
The mature active form of BMP2 (114 amino acids) was considered.
−
 
+
The sequence was condon optimized for E. coli
−
 
+
  
 
===Source===
 
===Source===
  
−
Human bone morphogenetic protein 2 from McCarthy, Yuan & Koria (2016).
+
Synthetized from IDT.
  
 +
===References===
 
McCarthy, B., Yuan, Y., & Koria, P. (2016). Elastin-like-polypeptide based fusion proteins for osteogenic factor delivery in bone healing. Biotechnology Progress, 32(4):1029-37.
 
McCarthy, B., Yuan, Y., & Koria, P. (2016). Elastin-like-polypeptide based fusion proteins for osteogenic factor delivery in bone healing. Biotechnology Progress, 32(4):1029-37.
−
 
−
===References===
 

Latest revision as of 06:33, 9 October 2018


Bone morphogenetic protein 2 (BMP2)


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

The mature active form of BMP2 (114 amino acids) was considered. The sequence was condon optimized for E. coli

Source

Synthetized from IDT.

References

McCarthy, B., Yuan, Y., & Koria, P. (2016). Elastin-like-polypeptide based fusion proteins for osteogenic factor delivery in bone healing. Biotechnology Progress, 32(4):1029-37.